Intermediate term results for iodine 125 brachytherapy for favourable risk prostate cancer for 556 patients

被引：0
|
作者：
Crook, J. [1 ]
Yeung, I. [1 ]
Gillan, C. [1 ]
McLean, M. [1 ]
Lockwood, G. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80883-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] Intermediate term results for iodine 125 brachytherapy for favorable risk prostate cancer
    Crook, J. M.
    Yeung, I.
    Gillan, C.
    McLean, M.
    Lockwood, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S330 - S330
  • [2] Long-term results of Iodine-125 seed brachytherapy in low and intermediate risk prostate carcinoma
    Guinot, J.
    Gonzalez-Perez, V.
    Casanova, J.
    Santos, M. A.
    De los Dolores, V.
    La Rosa, A.
    Sanchez-Rodriguez, A.
    Laborda, A.
    Canos, S.
    Cotanda, V.
    Guardino, C.
    Tortajada, M. I.
    Arribas, L.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S497 - S498
  • [3] Permanent iodine-125 seed brachytherapy for low and intermediate risk prostate cancer: 13 year results at a single australian institution
    Bece, A.
    Malouf, D.
    Chin, Y.
    Papadopoulos, B.
    Fisher, L.
    Enari, K.
    Thomson, P.
    Bucci, J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 10 - 10
  • [4] Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer
    Stone, NN
    Stock, RG
    Unger, P
    JOURNAL OF UROLOGY, 2005, 173 (03): : 803 - 807
  • [5] Iodine 125 brachytherapy for prostate cancer in Ravenna (Italy)
    Del Duca, M
    Palazzi, S
    Emiliani, E
    Giannini, M
    Dal Pozzo, C
    Di Stefano, C
    Severini, G
    Gnani, G
    Mazzotti, G
    Morelli, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S101 - S101
  • [6] Iodine 125 brachytherapy for favorable risk prostate cancer: Results for 509 patients. When can we start to trust PSA after brachytherapy?
    Crook, JM
    Gillan, C
    Yeung, I
    McLean, M
    Lockwood, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S296 - S296
  • [7] Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low- and intermediate-risk prostate cancer
    Guinot, Jose Luis
    Casanova, Juan
    Gonzalez-Perez, Victor
    Santos, Miguel Angel
    Dolores, Victor De los
    Tortajada, Maria Isabel
    Guardino, Carmen
    Crispin, Vicente
    Rubio-Briones, Jose
    Arribas, Leoncio
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (03) : 215 - 221
  • [8] Prostate Brachytherapy with Iodine 125 Implants in Patients with Intermediate Risk Prostate Cancer: A Highly Efficient Treatment when Compared with High Dose External Beam Radiotherapy
    Naji, S.
    Duberge, T.
    Boher, J.
    Bladou, F.
    Resbeut, M.
    Gravis, G.
    Walz, J.
    Levi, J. Hannoun
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S314 - S314
  • [9] Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: A population-based cohort study
    Herbert, Christopher
    Morris, W. James
    Keyes, Mira
    Hamm, Jeremy
    Lapointe, Vincent
    McKenzie, Michael
    Pickles, Thomas
    Spadinger, Ingrid
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 228 - 232
  • [10] Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer
    Takamoto, Atsushi
    Tanimoto, Ryuta
    Bekku, Kensuke
    Araki, Motoo
    Sadahira, Takuya
    Wada, Koichiro
    Ebara, Shin
    Katayama, Norihisa
    Yanai, Hiroyuki
    Nasu, Yasutomo
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 507 - 512
12345